✦ LIBER ✦

Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens

✍ Scribed by Keiji Chida; Hiroshi Nomura; Hidehiko Konno; Sadao Takase; Yasuto Itoyama

Book ID: 119470283
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 59 KB
Volume: 165
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(99)00095-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent Miller Fisher syndrome: clinic

Recurrent Miller Fisher syndrome: clinical and laboratory features

✍ J. G. Heckmann; M. Dütsch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

P12-17 Clinical features and laboratory

P12-17 Clinical features and laboratory findings of 7 cases with Miller-Fisher syndrome in ChoRay hospital

✍ T.T.Q. Le 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P631: Clinical features of recurrent Fis

P631: Clinical features of recurrent Fisher syndrome and Bickerstaff brainstem encephalitis

✍ Ishii, J.; Kawamoto, M.; Yoshimura, H.; Kohara, N. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Fisher syndrome: clinical features, immu

Fisher syndrome: clinical features, immunopathogenesis and management

✍ Mori, Masahiro; Kuwabara, Satashi; Yuki, Nobuhiro 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 729 KB

Clinical and immunological spectrum of t

Clinical and immunological spectrum of the Miller Fisher syndrome

✍ Y. L. Lo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Clinical and immunological spectrum of t

Clinical and immunological spectrum of the Miller Fisher syndrome

✍ Y. L. Lo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract The Miller Fisher syndrome (MFS), characterized by ataxia, areflexia, and ophthalmoplegia, was first recognized as a distinct clinical entity in 1956. MFS is mostly an acute, self‐limiting condition, but there is anecdotal evidence of benefit with immunotherapy. Pathological data remain